Paper2892019
Monoclonal anti-CD4 in arthritis.
Herzog C and 8 others. Lancet, 1987. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. Monoclonal anti-CD4 in arthritis. Papers, record 2892019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2892019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Differentiation, T-Lymphocyte | Major topic |
| Arthritis | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Psoriasis | Major topic |
| Humans |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34236494 | [80 milestones in rheumatology from 80 years- III. 1980-2000]. | Z Rheumatol | 2021 | https://conductscience.org/library/papers/34236494 | PubMed |
| 27365024 | [Biologics]. | Z Rheumatol | 2016 | https://conductscience.org/library/papers/27365024 | PubMed |
| 25676124 | [Pathogenic cells of rheumatic inflammation as the target of modern therapies]. | Z Rheumatol | 2015 | https://conductscience.org/library/papers/25676124 | PubMed |
| 21182494 | Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21182494 | PubMed |
| 20479941 | Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. | PLoS One | 2010 | https://conductscience.org/library/papers/20479941 | PubMed |
| 19490600 | Antibody engineering to develop new antirheumatic therapies. | Arthritis Res Ther | 2009 | https://conductscience.org/library/papers/19490600 | PubMed |
| 8920867 | T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. | J Exp Med | 1996 | https://conductscience.org/library/papers/8920867 | PubMed |
| 8814461 | The effects of mesoporphyrin on experimental arthritis in mice. | Inflamm Res | 1996 | https://conductscience.org/library/papers/8814461 | PubMed |
| 8485917 | Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/8485917 | PubMed |
| 8485910 | Synovial fluid antigen-presenting cell function in rheumatoid arthritis. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/8485910 | PubMed |
| 8287596 | The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells. | Clin Exp Immunol | 1994 | https://conductscience.org/library/papers/8287596 | PubMed |
| 8258242 | Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritis. | Clin Rheumatol | 1993 | https://conductscience.org/library/papers/8258242 | PubMed |
| 8187337 | Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. | Clin Exp Immunol | 1994 | https://conductscience.org/library/papers/8187337 | PubMed |
| 8103714 | In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/8103714 | PubMed |
| 8097975 | Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/8097975 | PubMed |
| 7875734 | T-cell receptor V beta repertoire of L3T4+ regulatory T cells in anti-L3T4 antibody-induced tolerant NOD mice. | Immunology | 1994 | https://conductscience.org/library/papers/7875734 | PubMed |
| 7679058 | Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/7679058 | PubMed |
| 7492226 | Treatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: a pilot study in two children. | Ann Rheum Dis | 1995 | https://conductscience.org/library/papers/7492226 | PubMed |
| 3055380 | New approaches to the treatment of rheumatoid arthritis. | Springer Semin Immunopathol | 1988 | https://conductscience.org/library/papers/3055380 | PubMed |
| 2786388 | Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. | Ann Rheum Dis | 1989 | https://conductscience.org/library/papers/2786388 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2892019
GET https://conductscience.org/api/papers/v1/2892019/cited_by?page=2